Lower Ticagrelor Dosing in the Dual Antiplatelet Regimen for Neurointerventional Procedures
Ticagrelor 60 mg for DAPT in intracranial stenting is safe and effective. Larger prospective studies may be required to validate these findings.
Authors
- Daryl Goldman (ORCID: https://orcid.org/0000-0002-4378-6707)
- Preethi Reddi (ORCID: https://orcid.org/0000-0002-7084-2567)
- Reade De Leacy (ORCID: https://orcid.org/0000-0001-9447-5338)
- Johanna T Fifi (ORCID: https://orcid.org/0000-0001-7786-5668)
- J Mocco (ORCID: https://orcid.org/0000-0001-5489-2524)
- Shahram Majidi (ORCID: https://orcid.org/0000-0003-2971-6216)
- Benjamin Yim (ORCID: https://orcid.org/0000-0003-3629-3194)
- Javin Bose (ORCID: https://orcid.org/0009-0009-2341-7363)
- Amol Mehta (ORCID: https://orcid.org/0009-0003-2967-1086)
- Joshua Finesilver (ORCID: https://orcid.org/0009-0006-2842-8983)
- Paramjit Sembhi
Institutions
- John Muir Health (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of NeuroInterventional Surgery
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1136/jnis-2024-022536
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.21